Sardona Therapeutics

Sardona Therapeutics is a privately held company based in San Francisco, California. With a team of 9 employees, the company focuses on developing innovative cancer treatments. Sardona Therapeutics specializes in precision oncology, developing small molecules that target RNA-binding proteins (RBPs). These molecules aim to modulate dysregulated RNA associated with tumor growth, offering a unique approach to combatting oncogenic drivers in cancer. Their therapies are designed to address clinically-validated targets, potentially leading to more effective cancer treatments. The company's differentiated approach to cancer treatment focuses on the modulation of RNA-binding proteins, a less explored area in oncology. This targeted approach aims to address the root causes of tumor growth, potentially leading to more effective and personalized cancer therapies. For more information about Sardona Therapeutics and their innovative cancer treatments, please visit their website at sardonatx.com.